http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190005535-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9cab2e30796f5762659d2597b216745 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-3262 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-19 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-065 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258 |
| filingDate | 2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f4f83e275e05066a851c23579e4d237 |
| publicationDate | 2019-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20190005535-A |
| titleOfInvention | Composition for lowering cholesterol comprising a mixture culture of Ginseng Berry-hongguk |
| abstract | The present invention provides a composition for lowering cholesterol comprising a ginseng fruit-red flounder mixed culture or containing it as an active ingredient. The mixed culture of the ginseng fruit-red flounder mixed culture or the ginseng fruit-thistle mushroom mycelium according to the present invention is characterized in that the content of rare ginsenoside is increased by the treatment and the mixed culture of the ginseng fruit and the physiological activity And therefore has an excellent cholesterol-lowering effect. Thus, the mixed culture of ginseng fruit-red flounder mixture or ginseng fruit-thistle mushroom mycelium according to the present invention can be used for the treatment of obesity, fatty liver, type 2 diabetes, hypertriglyceridemia, hypercholesterolemia, hyperlipidemia, dyslipidemia, Or a metabolic syndrome in which at least two of the above-mentioned diseases occur simultaneously, and the like. |
| priorityDate | 2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 699.